Many costly generic drugs are unavailable at Amazon, Cuban, and other alternative pharmacies; Biotech FogPharma raises $145 million

Taking stock of the drug industry, from the lab to the medicine chest

March 1, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Amazon STAT+ | Many costly generic drugs are unavailable at Amazon, Cuban, and other alternative pharmacies Prices also vary widely and savings can also be modest at these pharmacies, says Harvard's Benjamin Rome, a study co-author. By Ed Silverman STAT+ | Biotech FogPharma raises $145 million in anticipation of more clinical trials, pharma partnerships The company is developing cancer treatments using corkscrew-shaped peptides called helicons that could possibly better breach cells. By Allison DeAngelis STAT+ | Here are the cancer drugs Pfizer thinks could reignite investors' interest In describing drugs in its pipeline, Pfizer noted that the mix of small molecule drugs in its cancer portfolio will drop from 94% last year to 35% in 2030. By Matthew Herper Adobe More than 1 billion people have obesity, including 159 million young people, study estimates Obesity rates for children and teens quadrupled since 1990. Rates also rose in Pacific islands, Middle East, North Africa and the Caribbean. By Elaine Chen

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser